CAP Letter Urges Trump Administration to Rescind FDA's LDT Regulation
November 21, 2024
November 21, 2024
NORTHFIELD, Illinois, Nov. 21 -- The College of American Pathologists issued the following news release:
The College of American Pathologists (CAP) has asked leaders of the Trump Transition Team to recommend the incoming administration rescind the Food and Drug Administration's (FDA) proposed regulation of laboratory-developed tests (LDTs), citing significant concerns about the rule's potential to limit patient access to critical diagnostic services.
In a letter address . . .
The College of American Pathologists (CAP) has asked leaders of the Trump Transition Team to recommend the incoming administration rescind the Food and Drug Administration's (FDA) proposed regulation of laboratory-developed tests (LDTs), citing significant concerns about the rule's potential to limit patient access to critical diagnostic services.
In a letter address . . .